Tuesday, September 8, 2020

Centre issues SOP for partial reopening of schools for classes 9-12 from 21 Sept.


 Centre issues SOP for partial reopening of schools for classes 9-12 from 21 Sept.
IMG_20200908_222506

Assemblies, sports and events, which can lead to overcrowding, are strictly prohibited in the schools that are opting to start operations
 “Students of class 9th to 12th shall be permitted to visit their school on voluntary basis for taking guidance from their teachers. This will be subject to written consent of their parents/guardians. Such visits and teacher – student interaction must be organized in a staggered manner," state the standard operation procedures (SOPs) issued by the health ministry.

Further, students, teachers and employees living in containment zones will not be allowed to attend the school. Students, teachers and employees shall also be advised not to visit areas falling within containment zones as per the health ministry guidelines adding that the schools that were used as quarantine centres will be properly sanitized and deep cleaned before partial functioning is resumed.

Only asymptomatic people (teachers, employees and students) will be allowed in the school premises as per the guidelines. If a teacher/employee/student is found to be symptomatic, he/she should be referred to nearest health centre, the SOPs state.

The guidelines stated that the concerned teaching- and non-teaching employees (up to 50 % of the strength) may be called to schools for online teaching/tele-counselling and related work. Apart from mandatory masks, following regular sanitisation, respiratory etiquettes, hand washing in schools, the health ministry said that at all times, the teachers and students shall maintain a physical distancing of 6 feet apart, wherever feasible. Seating arrangement has to ensure a distance of 6 feet between chairs, desks etcAbout four of them have already come forward, the others are in talks with the Russian counterparts and the Government is facilitating that process of creating a connect. There may be specific outcomes very soon in that regard. India can manufacture that vaccine in large and significant quantities. On the regulatory front, Indian scientists have looked at the data. There would be a need for Phase III trials in normal course of things," he said

AAJTAK NEWS||Divya Bhaskar
Share:

Followers

આપ સૌનુ હાદિઁક સ્વાગત છે.

આપ સૌનુ હાદિઁક સ્વાગત છે.

Blog Archive